Erschienen in:
22.05.2018 | Editorial
Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile?
verfasst von:
Pierre Attal, Philippe Chanson
Erschienen in:
Endocrine
|
Ausgabe 1/2018
Einloggen, um Zugang zu erhalten
Excerpt
The prevalence of obstructive sleep apnea (OSA) is very high in the general population (i.e., between the ages of 50 and 70 years, it is around 61 and 37%, in men and women, respectively). It is dependent essentially on age, sex and body mass index [
1]. There has been a dramatic increase in the incidence of OSA over the last decades, mostly attributed to an epidemic of obesity [
1,
2]. Conversely, the prevalence of acromegaly is very low, ranging from 2.8 to 13.7 cases per 100,000 [
3]. This comparative rarity is probably one of the reasons why its diagnosis is challenging and often made only after a delay of many years [
3], and due to the very gradual and progressive installation of the dysmorphic syndrome which is characteristic of the disease [
4]. …